Agenda

25 CE/CME Credits (7 In-Person and 18 Online)

After completing this activity, participants will be able to:

  • Identify the evidence for emerging pharmaceutical and device-based therapies for common pediatric and adult skin conditions
  • Incorporate the use of biologics and JAK inhibitors into an integrative treatment plan for inflammatory skin conditions
  • Examine the clinical evidence for influence of epigenetic markers on aging and skin inflammation
  • Diagram the role of the gut and skin microbiome in inflammation and the skin barrier
  • Discuss the clinical evidence for the use of non-steroidal topicals to control skin inflammation
  • Compare treatment approaches based on skin type and color

.

Join The List

Sign up to receive exclusive discounts and special offers